Effect of Muraglitazar on Death and Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus
Year: 2005
Type: article
Source: JAMA
Authors: Steven E. Nissen, Kathy Wolski, Eric J Topol
Institution: Cleveland Clinic
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: muraglitazar, type 2 diabetes, major adverse cardiovascular events, cardiovascular safety, PPARγ agonists, pioglitazone, myocardial infarction, stroke, congestive heart failure, transient ischemic attack, death, metformin, glibenclamide, FDA advisory committee, drug approval, glycemic control, adverse drug reactions
Open Access status: closed
OpenAlex ID: W2165815833
